Tregoning Kathleen 4
4 · Spero Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Tregoning Kathleen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02$1.12/sh+35,604$39,876→ 35,604 totalExercise: $1.52Exp: 2034-01-02→ Common Stock (35,604 underlying)
Footnotes (2)
- [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
- [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $40,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.